+6.0%
CLSK vs GSK
+47.2%
-41.2%
-92.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +6.8% | 0.0% | +6.8% | +6.8% |
| 7D | +7.7% | -3.5% | +11.3% | +8.2% |
| 30D | +12.2% | -3.4% | +15.7% | +12.5% |
| 3M | -15.5% | -8.1% | -7.3% | -14.9% |
| 6M | +39.3% | -11.1% | +50.5% | +41.4% |
| YTD | +35.1% | +0.7% | +34.3% | +32.9% |
| 1Y | +34.0% | +20.1% | +13.9% | +25.2% |
| 3Y | +226.3% | +46.1% | +180.1% | +172.9% |
| All | +6.0% | +47.2% | -41.2% | -28.7% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling